Submitted by Anonymous (not verified) on 15 October 2026 - 11:00
Human medicines European public assessment report (EPAR): Koselugo, selumetinib, Date of authorisation: 17/06/2021, Revision: 10, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Koselugo, selumetinib, Date of authorisation: 17/06/2021, Revision: 10, Status: Authorised